Home/Filings/4/0001062993-24-012089
4//SEC Filing

Burgess Vincent J 4

Accession 0001062993-24-012089

CIK 0001561921other

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 5:00 PM ET

Size

7.2 KB

Accession

0001062993-24-012089

Insider Transaction Report

Form 4
Period: 2024-06-04
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-04+6,2006,200 total
    Exercise: $5.71Exp: 2034-06-04Common Stock (6,200 underlying)
  • Award

    Common Stock

    2024-06-04+4,25015,380 total
Footnotes (2)
  • [F1]These restricted stock units vest on the earlier of (a) June 4, 2025, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
  • [F2]The option vests on the earlier of (a) June 4, 2025, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

Issuer

TELA Bio, Inc.

CIK 0001561921

Entity typeother

Related Parties

1
  • filerCIK 0001365408

Filing Metadata

Form type
4
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 5:00 PM ET
Size
7.2 KB